Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity

Francesca Bedussi,Diego Galli,Martina Fragni,Francesca Valcamonico,Elisa Rossini,Alberto Dalla Volta,Sara Vezzoli,Elisa Roca,Vittorio Ferrari,Barbara Lazzari,Maurizio Memo,Sandra Sigala,Alfredo Berruti

Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity

2017

Francesca Bedussi
Diego Galli
Martina Fragni
Francesca Valcamonico
Elisa Rossini
Alberto Dalla Volta
Sara Vezzoli
Elisa Roca
Vittorio Ferrari
Barbara Lazzari
Maurizio Memo
Sandra Sigala
Alfredo Berruti

Background: The administration of abiraterone acetate (abiraterone) leads to an adrenocorticotropic hormone (ACTH)-driven increase in mineralocorticoid hormones,

Keywords:

Hormone
Abiraterone acetate
Mineralocorticoid excess
Adrenocorticotropic hormone
Endocrinology
Internal medicine
Abiraterone
Diabetes mellitus
Amiloride
Chemistry
Mineralocorticoid
Pharmacology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations